Ovarian Cancer Drugs Market Growth Rate, Statistics, Segment and Forecast| Roche, Amgen, Boehringer Ingelheim

  


Ovarian cancer is a type of cancer that affects the female reproductive organs. In 2012, the World Health Organization reported that 2,38,700 women were diagnosed with ovarian cancer. The report examines the demand for ovarian cancer medications, which is expected to contribute to the market's growth. It focuses on both generic and brand-name medications used to treat ovarian cancer, as well as their commercial impact.

The rising incidence of ovarian cancer is driving the market. The demand for more effective treatment alternatives is propelling the industry forward. While generics like paclitaxel and carboplatin now dominate the market, medications like Bevacizumab (Avastin) and Pazopanib (Votrient) are projected to drive growth. This market faces a difficulty in developing medications with higher efficacy. The development of novel medications to treat ovarian cancer is a potential for this market.

The ovarian cancer drugs market is divided into four regions: North America, Europe, Asia Pacific, and Latin America and the Caribbean. Because of the high prevalence of ovarian cancer in North America, it is the most lucrative market. According to the American Cancer Society, 21,980 women in the United States will be diagnosed with ovarian cancer in 2014. Because of the high incidence of ovarian cancer in Europe, it is the second largest market.

The drugs used to treat ovarian cancer include  Paclitaxel, Cisplatin, Adriamycin PFS (Doxorubicin Hydrochloride), Carboplatin, Cyclophosphamide, Platinol (Cisplatin), Paraplatin (Carboplatin), Evacet (Doxorubicin Hydrochloride Liposome), Cytoxan (Cyclophosphamide), Paraplat (Carboplatin), Taxol (Paclitaxel) (Cyclophosphamide).

Roche, Amgen, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, and others are among the firms involved. Roche's medicine Avastin (bevacizumab) was approved by the European Union in December 2011 for use in the treatment of ovarian cancer in combination with carboplatin and paclitaxel.

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area